Week3: influenza viruses Flashcards
Genomic organization of influenza virus
GENOME
-single stranded negative sense linear RNA virus
-8 segmented genome for A and B, 7 for C
VIRION
-enveloped particles, quasi spherical
-envelope from host cell plasma by budding
Genes and proteins of influenza
GENES/PROTEINS
- PB1/2, PA: polymerase, error prone
- HA: Hemaglutinin
- NP: nucleocapsid
- NA: neuraminidase, cleaves bound silica acid to release virus from infected cells
- M1: matrix protein
- M2: membrane protein, forms membrane channel, facilitates uncoating, HA production
- NS1/2: nonstructural protein, nuclear export protein. Only present during replication
Influenza virus replication cycle
- Binding to silica acid containing receptors, Uses HA protein for binding. virus is endocytosed
- Fuses with vesicle membrane. M2 . protein pumps acid to acidify endosome and uncoat virus
- Transcription in nucleus
- Protein synthesis
- Replication of genome in nucleus
- Assembly
- budding from plasma membrane. Uses NA to cleave sialic acid.
Influenza A vs Influenza B
INFLUENZA A -can affect humans, birds, pigs -most common and usually causes the most serious epidemics INFLUENZA B -milder than A
2009 H1N1 Swine flu
- pandemic of Influenza A, 5/8 genomic RNAs were of swine origin
- caused greater disease burden in people younger than 25 than older people
- in animal models, caused more lung damage and can replicate more efficiently in trachea and deep lung compared to seasonal flu.
Flu symptoms and complications
SYMPTOMS
-fever, myalgia, headache, malaise, nonproductive cough, sore throat, rhinitis
-children: GIT symptoms, otitis media, myositis, croup
COMPLICATIONS
-exacerbation of underlying pulmonary or cardiac disease
-secondary bacterial pneumonia
-primary influenza viral pneumonia
-neuro syndrome: guillain barre, encephalitis, Reye’s
Pathogenesis of influenza virus
- cytopathic effect caused by viral replication: epithelial tissue loss
- kills ciliated epithelial cells in URT, desquamation of bronchial or alveolar epithelium - Immunopathologic effect caused by host: epithelial tissue damage and systemic flu like symptoms
- inflammatory response - Bacteria super infection: viral infection exposes binding site for bacteria and promotes bacteria adhesion
Antigenic drift Vs antigenic Shift
- Drift
- error prone RNA polymerases facilitates major genetic changes, esp on HA and NA proteins
- small mutations - Shift
- segmented genome structure and co-infection lead to genetic reassortment
- coinfection with animal and human strains can generate very different virus strains
- can result in Pandemics
Treatment of influenza
- M2 as drug target: only for A. Prevents acidification for HA and preventing uncaring and release of influenza A virus
- Adamantanes (amantadine and rimantidine): Influenza A has developed resistance to them, not recommended. - Neuraminidase (NA) target
- works for A and B
- virions are attached via HA to cell membrane gp/glycolipids
- NA inhibitors prevent cleavage of sialic acid residue, so virus isn’t released from infected cell
- Zanamivir and Oseltamivir
Vaccinations for flu
- Inactivated vaccines
- persons >6 months - Live attenuated vaccine
- 5-49 yo. Not for pregnant women. But has higher protection.